ATRA
Atara Biotherapeutics Inc
NASDAQ: ATRA · HEALTHCARE · BIOTECHNOLOGY
$4.77
+3.70% today
Updated 2026-04-30
Market cap
$40.97M
P/E ratio
1.95
P/S ratio
0.34x
EPS (TTM)
$2.57
Dividend yield
—
52W range
$4 – $19
Volume
0.3M
Atara Biotherapeutics Inc (ATRA) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-2.48M | $-5.97M | $-16.63M | $-37.16M | $-60.02M | $-87.50M | $-179.77M | $-235.63M | $-180.76M | $-220.52M | $-270.43M | $-192.98M | $-68.72M | $-50.94M |
| Capital expenditures | $27000.00 | $3000.00 | $46000.00 | $290000.00 | $3.02M | $20.23M | $35.92M | $5.73M | $4.51M | $10.58M | $4.19M | $1.22M | $246000.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $876000.00 | $1.71M | $10.10M | $10.25M | $16.78M | $23.10M | $33.82M | $51.70M | $51.35M | $53.87M | $53.84M | $45.39M | $27.00M | $9.75M |
| Free cash flow | $-2.50M | $-5.97M | $-16.67M | $-37.45M | $-63.05M | $-107.73M | $-215.70M | $-241.36M | $-185.27M | $-231.10M | $-274.62M | $-194.20M | $-68.96M | $-50.94M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | $0.00 | $0.00 | $0.00 | $0.00 | — | $6.70M | $1.52M | $1.24M | $623000.00 | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | $-29.72M | $1.85M | $24.22M | $31.25M | $-18.52M | $13.62M | $126.09M | $-94.32M | $-14.39M | — | — | — |